Background We previously reported that 6 to 12 weeks of dual-chamber (DDD) pacing results in clinical and hemodynamic improvement in obstructive hypertrophic cardiomyopathy (HCM). This study examines the long-term results of DDD pacing in obstructive HCM.
Background We previously reported that 6 to 12 weeks of dual-chamber (DDD) pacing results in clinical and hemodynamic improvement in obstructive hypertrophic cardiomyopathy (HCM). This study examines the long-term results of DDD pacing in obstructive HCM.
Methods and Results DDD devices were implanted in 84 patients (mean age, 49±16 years) with obstructive HCM and severe drug-refractory symptoms. At a mean follow-up of 2.3+0.8 years (maximum, 3.5 years), the New York Heart Association (NYHA) functional class had improved significantly (1.6±0.6 versus 3.2--0.5, P<.00001). Symptoms were eliminated in 28 patients (33%), improved in 47 patients (56%), but remained unchanged in 7 patients (8%). Two patients died suddenly (97% cumulative 3-year survival rate).
In 74 patients with significant left ventricular outflow tract (LVOT) obstruction at rest, the LVOT gradients were significantly reduced at follow-up (27+ 31 versus 96±41 mm Hg, P<.00001). Symptoms and provokable LVOT gradients were also reduced in all 10 patients without significant resting but with provokable LVOT obstruction. Persistence of the LVOT obstruction and symptoms was attributed to inability to preexcite the interventricular septum (n=8) and onset of atrial fibrillation (n=7). Fifty There was a weak but significant correlation between the reduction in LVOT gradients accomplished by AV pacing before implantation of DDD device and the eventual reduction in LVOT gradients recorded at the follow-up evaluation (r=.38, P=.0017). Echocardiography demonstrated significant thinning of the anterior septum and distal anterior LV wall in the absence of deterioration of LV systolic function. Conclusions (1) Although most of the improvement of symptoms and hemodynamic indexes occurs during the first few months of DDD pacing, further changes are often observed a year later; (2) DDD pacing is associated with an excellent prognosis in a subgroup of severely disabled patients, many of whom present with syncope or presyncope; (3) baseline pacing studies are not essential to identify patients who may benefit from pacing; (4) preexisting left bundle branch block is compatible with severe LVOT obstruction, and DDD pacing is also beneficial in this subgroup; (5) DDD pacing reduces both resting and provokable LVOT obstruction; (6) additional therapy, for example, radiofrequency ablation of the AV node, may be necessary in some patients either to preexcite the interventricular septum or to control atrial fibrillation; and (7) although LV hypertrophy has been considered a primary feature of HCM, pacing appears to reverse LV wall thickness in a significant subset of adult HCM patients. (Circulation. 1994 
Echocardiography
Echocardiographic studies were performed with a HewlettPackard (Sonos 1000) real-time, phase array, 900 ultrasonic scanner with a 2.5 -MHz transducer. The magnitude and distribution of LV hypertrophy were assessed in a number of standard cross-sectional planes. Diastolic wall thickness was measured directly from the television monitor with calipers at both the mitral valve and papillary muscles. M-mode echocardiograms were derived from the two-dimensional image under direct anatomic visualization. In the short axis, the LV wall was divided into four segments both at the mitral valve level (basal anterior septum, basal posterior septum, basal anterior free wall, and basal posterior free wall) and at the level of the papillary muscle (distal anterior septum, distal posterior septum, distal anterior free wall, and distal posterior free wall).
Changes in LV segmental wall thickness and motion were assessed by two independent observers who were unaware of the clinical findings or other results of the study. Paradoxical septal motion was defined as motion of the interventricular septum toward the right ventricle during systole determined by M-mode echocardiography. The severity of systolic anterior motion was graded as follows: 0, absent; 1+, present with minimum distance between mitral valve and ventricular septum during systole >10 mm; 2+, without mitral-septal contact but with a distance of <10 mm between mitral valve and septum during systole; 3+, brief mitral-septal contact (<30% of the time between closure and opening of the mitral valve); 4+, prolonged apposition of mitral valve with septum (>30% of the time between closure and opening of the mitral valve). Continuous-wave Doppler examination estimated the magnitude of the LVOT gradient using a 1.9-MHz nonimaging transducer." Particular care was taken to separate the LVOT signal from that of mitral regurgitation." The presence and severity of mitral regurgitation was assessed by color flow Doppler according to previously validated criteria. 12 
Cardiac Catheterization
Right heart pressures and cardiac output were measured with a thermodilution Swan-Ganz catheter. The LVOT gradient was recorded using the side arm of a Cordis 8F sheath and a 7F Cordis end-hole catheter placed in the LV. The right femoral and ascending aortic pressures were compared and agreed within 5 mm Hg. All patients had significant LVOT obstruction, defined as a subvalvular gradient of >30 mm Hg at rest or >55 mm Hg after provocation (amyl nitrite inhalation, Valsalva maneuver, or isoproterenol infusion).
At the baseline study, after measurement of right and left heart pressures and cardiac outputs during normal sinus rhythm, the hemodynamic indexes were remeasured during right atrial (RA) and AV sequential (AV delay of 120 milliseconds) pacing modes at a heart rate of 120 beats per minute. At the follow-up study, the hemodynamic indexes were recorded during sinus rhythm and DDD pacing and in addition, during RA and AV sequential pacing modes at a heart rate of 120 beats per minute by external programming of the pacemaker device.
Fifty patients had two cardiac catheterization evaluations, 3±1 and 16±4 months after implantation of the permanent DDD pacing device.
Radiofrequency Ablation of the AV Node
To control ventricular rate without using drugs and to ensure ventricular preexcitation, patients who developed paroxysmal or chronic atrial fibrillation were treated with radiofrequency ablation of the AV node, and their pacemakers were programmed to DDI/DDIR or VVIR modes, respectively. A 7F steerable catheter with a 4-mm distal pole (MansfieldWebster, Bard, or EPT) was positioned across the tricuspid valve. Attempts were made to perform ablation near the site at which the distal bipolar pair of electrodes recorded relatively large right atrial electrograms and a sharp His-bundle deflection. A Radionics RFG-3C radiofrequency current generator (Radionics Inc) provided the energy source. Radiofrequency energy was delivered for up to 60 seconds at 50 to 75 W between the distal electrode and a patch electrode (Bard Dispersive Electrode) positioned between the scapulae. Acceptable ablation end points were slowing of the ventricular response to <70 beats per minute during atrial fibrillation or onset of complete heart block. 
Implantation of Permanent

Follow-up Evaluation
Patients were scheduled for in-hospital follow-up evaluations at 2 to 3 months and >1 year after DDD pacemaker implantation. Repeat investigations included history and physical examination, 12-lead ECG, chest radiograph, echocardiogram, treadmill exercise tests, and right and left heart catheterization. Follow-up data were obtained during DDD pacing and with the pacemaker switched off during normal sinus rhythm. Long-term follow-up also included clinical assessment at intervals of 6 or 12 months and telephone follow-up with patients, relatives, and physicians.
Statistical Analysis
Data are expressed as mean+1 SD. Only paired data were compared by Student grammed to VVIR in 7 patients because of development of chronic atrial fibrillation and to DDIR in 2 patients because of paroxysmal atrial fibrillation.
The most common initial programmed AV delays were 120 (n=36) and 125 (n=37) milliseconds. However, some patients required shorter AV delays of 80 (n=1), 100 (n=7), and 110 (n=1) milliseconds to ensure septal preexcitation. In two patients, satisfactory septal electrical activation was achieved at the longer AV delays of 130 and 150 milliseconds. At follow-up evaluations, the AV delay was shortened in 8 patients (10%) to ensure greater interventricular septal preexcitation. However, in 15 patients (18%), the AV delay was increased after radiofrequency ablation of the AV node (n=8) or because of prolongation of intra-atrial conduction (abnormally prolonged P wave) in association with a long PR interval (n=7). Hence in sinus rhythm (P<.0001), but at the baseline study, a change from right atrial pacing at 120 beats per minute to AV pacing at 120 beats per minute reduced the LVOT gradient by 31±34 mm Hg (Fig 3) . There was significant correlation (r=.38, P<.0017) between changes in LVOT gradients induced by AV pacing recorded at the baseline cardiac catheterization and the eventual reduction in LVOT gradients noted at the follow-up study (Fig 3) . There were, however, notable disparities: For example, in one patient, AV pacing reduced LVOT gradient by only 20 (Fig 2) . Fifty patients had two cardiac catheterization evaluations. Most of the reduction in LVOT gradient occurred within 3 months of implantation of the permanent DDD device. However, there was a further significant decrease in LVOT gradient after a further 1 year of DDD pacing (Fig 4) . Fig 5 illustrates the progressive reduction in LVOT gradient in such a patient. The reduction in LVOT obstruction was not accompanied by a significant change in LV filling pressures or cardiac output (Fig 4) . recorded at the second evaluation (Fig 6) . Additionally, there was evidence of progressive significant reduction in LV end-diastolic pressure (Fig 6) . The (Fig 7) .
Results of DDD Pacing in Patients With LBBB Fifteen patients had LBBB before DDD pacing. These patients had evidence of severe LVOT obstruction despite the abnormal septal electrical activation finding (Fig 8) . Furthermore, DDD pacing (right ventricular apical electrical activation) was also effective in reducing LVOT obstruction without increasing LV filling pressures and reducing cardiac output in this subgroup of patients (Fig 8) . Echocardiographic Evidence of Reduction of LVOT Obstruction and Regression of Left Ventricular Wall Thickness After Chronic DDD Pacing
Baseline and follow-up echocardiograms of sufficient quality for comparison were available in 48 patients. At the level of mitral valve septal coaptation, DDD pacing caused clear-cut paradoxical interventricular septal motion in 21 patients (44%). In most of the remaining patients, DDD pacing induced less prominent alterations in septal motion, often eliminating or reducing the inward systolic movement of the interventricular septum. These findings were associated with significant reduction of systolic anterior motion, LVOT blood velocities, and mitral regurgitation ( Table 2) .
Chronic DDD pacing did not significantly alter LV diastolic dimension. However, largely as the conse- 
Discussion
Our long-term evaluation of DDD pacing in obstructive HCM confirms that this novel therapy is highly effective in relieving severe symptoms refractory to drug therapy. Angina, dyspnea, palpitations, and symptoms of impaired consciousness are eliminated or decreased in 89% of the patients. This symptomatic improvement is associated with significant reduction in LVOT obstruction, reduction in pharmacotherapy, and improvement in exercise performance. Notably, our study demonstrates that the symptomatic and hemodynamic benefits recorded early after implantation of DDD pacemaker often become more pronounced with the passage of time. At present it is unclear why in some patients LVOT obstruction is eliminated almost immediately, but in others, maximal results are observed only after more than a year of DDD pacing.
An important limitation of this study is that the severity of LVOT obstruction in HCM may vary markedly in the same patient under different conditions. To study the effects of DDD pacing on LVOT obstruction, therefore, requires that a large number of well-characterized patients with obstructive HCM be studied under standardized conditions. The patients in this study were of two types: The largest subgroup consisted of patients in whom prior echocardiographic and cardiac catheterization studies had invariably demonstrated significant LVOT at rest. A much smaller subgroup comprised patients who consistently did not have evidence of LVOT obstruction at rest by noninvasive and invasive studies but in whom severe LVOT obstruction could readily be provoked by isoproterenol infusion. Both groups of patients with obstructive HCM derived benefit from DDD pacing.
A gratifying result was the reduction in symptoms of impaired consciousness. Syncope has been associated with a poor prognosis (about 4% to 6% annual mortality) in HCM.14-16 However, even though almost half of the patients in the present study presented with syncope or presyncope and most had severe congestive symptoms, only two sudden deaths occurred during the 2.5-year period of follow-up (about 1% annual mortality). This compares favorably with the probable 8% to 10% cumulative mortality had the patients been subjected to cardiac surgery. Given the satisfactory results in most patients who receive DDD pacemakers and the relative simplicity of this approach compared with cardiac surgery, it is most unlikely that it will ever be possible to compare the two modes of therapy through a randomized prospective study. We believe that cardiac surgery will be reserved for only a minority of patients who fail to respond to DDD pacing or who have independent mitral valve disease (severe mitral regurgitation due to mitral valve prolapse, or aberrant papillary muscle obstructing LV outflow).
We have also previously reported that when, after several weeks of pacing, the DDD device is switched off and recordings are made in normal sinus rhythm, the hemodynamic indexes and cardiac electrical properties are often noted to have changed profoundly.817 The present study confirms this finding and demonstrates that the adaptive hemodynamic changes recorded early after implantation of the pacemaker are exaggerated after a longer period of DDD pacing. A molecular basis for the adaptive cardiac changes is at present being investigated. Further studies are also necessary to establish whether the changes in hemodynamic indexes and cardiac electrical properties reduce the tendency to atrial and ventricular arrhythmias.
A finding of practical importance is that detailed invasive evaluation of the hemodynamic consequences of AV sequential pacing before implantation of DDD pacemaker poorly identifies patients with obstructive HCM, who are most likely to benefit from this novel therapy, and is therefore unnecessary. It is therefore even less likely that indirect studies of the effects of temporary AV sequential pacing on LVOT gradient, such as Doppler echocardiography, will assist in the selection of such patients. There Although this procedure may render the patient dependent on the pacemaker, it can be justified if it results in relief of the LVOT obstruction and thus precludes the need for major cardiac surgery. Atrial fibrillation is the most common supraventricular arrhythmia recorded in HCM.17,l8 Sudden loss of atrial contribution, tachycardia, and irregular LV filling and emptying can have devastating hemodynamic consequences and precipitate sudden death. [17] [18] [19] We have previously reported that radiofrequency ablation of the AV node coupled with rate-responsive pacing results in satisfactory symptomatic and hemodynamic outcome in HCM patients with atrial fibrillation.20 Although the relief of LVOT obstruction and consequently, reduction of mitral regurgitation and of left atrial pressures may help prevent atrial arrhythmias, our study did not provide evidence to support this. Conversely, ventricular pacing with retrograde atrial activation due to inability to sense P waves satisfactorily could precipitate atrial fibrillation. However, there was no evidence of pacemaker malfunction, such as failure to sense P waves, in the patients who developed atrial fibrillation. The baseline left atrial dimensions in the patients were also not significantly different from those in patients who did not develop atrial fibrillation. Furthermore, the left atrial dimensions did not significantly change during follow-up. These findings suggest that the atrial fibrillation was the consequence of progression of atrial electrical disease that was not significantly affected by DDD pacing. In some patients, an attempt was made to maintain sinus rhythm by prescribing antiarrhythmic drugs. If this failed, then to prevent the dire clinical consequences of atrial fibrillation and to ensure satisfactory pacing, we performed radiofrequency modification/ablation of the AV node and programming of the pacemaker to mode switching (DDI) in patients with paroxysmal atrial fibrillation and rate-responsive ventricular demand (VVIR) pacing in patients with chronic atrial fibrillation.
This study also reveals another important consequence of chronic DDD pacing in obstructive HCM: The anterior basal and distal septal segments and posterior distal septal segment thinned significantly in 23% of the patients. In the remaining patients, the LV wall thickness was unchanged or the LV wall thinning was less prominent. Importantly, the reversal of the LV wall thickness was segmental and not global, was associated with amelioration of symptoms, and was not accompanied by diminution of LV function. When pacing was discontinued, the LV fractional shortening had not altered significantly, and the hemodynamic findings were improved: LV end-diastolic, pulmonary arterial capillary wedge, and mean pulmonary arterial pressures had decreased, systemic arterial pressure had increased, and cardiac outputs were maintained. We have also reported that DDD pacing in obstructive HCM improves myocardial perfusion as demonstrated by exercise 201T1 scintigraphy. 21 Recently, in studies involving small numbers of patients, Sadoul et a122 and Jeanrenaud et a123 also reported small decreases in LV mass with minor or no alteration of LV cavity dimensions and hence, of LV function.
It has been suggested that the decrease in LV hypertrophy may be due to the reduction of the LVOT obstruction. However, we have not found a correlation between the reduction in LVOT gradient and the change in LV wall dimensions. Furthermore, a similar thinning of the LV wall has not been observed in patients who have undergone successful LV septal myotomy and myectomy. Hence, the reversal of LV wall thickness may be a direct consequence of pacing and not secondary to the reduction of LVOT obstruction.
Recent animal studies have demonstrated that during LV contraction after activation of the specialized HisPurkinje system, there is homogeneity of myocardial fiber strain and stress. 24 In contrast, asynchronous electrical activation during LV apical pacing in dogs has been shown to reduce fiber strain in areas of early electrical activation.25 The altered workload has been associated with a reduction in LV mass near the pacing site. 26 In a further recent retrospective study, in patients with LBBB, M-mode echocardiographic examination showed LV wall thickness to be significantly less in the early activated septum than in the late activated posterior wall. 27 The reduction in LV wall thickness in our patients was more impressive than that reported in animals and occurred both near the pacing site and distally (basal anterior septum). Therefore, an explanation for the changes in LV mass may be that right ventricular apex causes early activation of the anterior septum and more delayed electrical activation of the posterior septum, posterior LV free wall, and anterolateral LV free wall. This, in turn, causes important segmental differences in contractile work and hence changes in LV mass. The exciting finding of regression of LV hypertrophy in a subset of adult HCM patients has prompted us to prospectively investigate the distinct possibility that in children, DDD pacing may attenuate the LV hypertrophy and prevent LVOT obstruction from developing during the period of most rapid growth (puberty).
